Wageningen is going to give non-profit organizations free access to a number of CRISPR-Cas patents as a stimulus for plant-breeding in emerging economies. But the technical and legal details are being worked out first. ‘We do want to monitor how our licence is applied.’ TEXT ARNO VAN ’T HOOG ILLUSTRATION RHONALD BLOMMESTIJN
Wageningen World 04 2021 (in English)
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.